bioAffinity Technologies, Inc. (BIAF) can sell. Click on Rating Page for detail.
The price of bioAffinity Technologies, Inc. (BIAF) is 2.71 and it was updated on 2024-07-27 07:01:05.
Currently bioAffinity Technologies, Inc. (BIAF) is in undervalued.
News |
---|
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
|
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
|
bioAffinity Technologies News Update
|
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
|
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
|
StockPrice Release |
---|
Bioaffinity technologies news update
|
Bioaffinity technologies in the news
|
Bioaffinity technologies in the news
|
News |
---|
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
|
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
|
bioAffinity Technologies In The News
|
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
|
bioAffinity Technologies In the News
|
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
|
CMS Posts Final Payment Determination for bioAffinity Technologies' CyPath® Lung Effective January 2024
|
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
|
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
|
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
|
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
|
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
|
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
|
Stock Market Today: What Happened & 3 Penny Stocks To Watch Now
|
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
|
Penny Stocks to Buy in a Bear Market? 3 to Watch Right Now
|
Why Is BioAffinity (BIAF) Stock Up 40% Today?
|
What Is Going on With bioAffinity (BIAF) Stock Today?
|
bioAffinity (BIAF) Stock Pops 100% in Red-Hot IPO
|